Correlation Between Karyopharm Therapeutics and Mustang Bio
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Mustang Bio, you can compare the effects of market volatilities on Karyopharm Therapeutics and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Mustang Bio.
Diversification Opportunities for Karyopharm Therapeutics and Mustang Bio
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Karyopharm and Mustang is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Mustang Bio go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Mustang Bio
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Mustang Bio. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 1.53 times less risky than Mustang Bio. The stock trades about -0.65 of its potential returns per unit of risk. The Mustang Bio is currently generating about -0.23 of returns per unit of risk over similar time horizon. If you would invest 20.00 in Mustang Bio on September 25, 2024 and sell it today you would lose (3.57) from holding Mustang Bio or give up 17.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Mustang Bio
Performance |
Timeline |
Karyopharm Therapeutics |
Mustang Bio |
Karyopharm Therapeutics and Mustang Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Mustang Bio
The main advantage of trading using opposite Karyopharm Therapeutics and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Mustang Bio vs. Fate Therapeutics | Mustang Bio vs. Caribou Biosciences | Mustang Bio vs. Karyopharm Therapeutics | Mustang Bio vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |